NRX Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- NRX Pharmaceuticals Inc.
- Former names
- Big Rock Partners Acquisition Corp.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Wilmington
- Headquarters state / province
- Delaware
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NRXP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001719406
- EIN
- 82-2844431
Board of directors
-
Aaron Gorovitz · DirectorSince 2023
-
Chaim Hurvitz · DirectorSince 2023
-
Dennis McBride · DirectorSince 2024
-
Janet Rehnquist · DirectorSince 2023
-
Jonathan C. Javitt · Director · Chairman and Chief ScientistSince 2023
-
Patrick John Flynn · DirectorSince 2025
Director election results
Annual meeting of March 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 17, 2024 | Jonathan C. Javitt Director, Officer (Chairman and Chief Scientist), 10% owner | Open-market purchase | +40,000 | $1.17 | $46,800 |
| Aug 30, 2023 | Aaron Gorovitz Director | Open-market purchase | +35,000 | $0.32 | $11,200 |
| Aug 30, 2023 | Chaim Hurvitz Director | Open-market purchase | +70,000 | $0.29 | $20,300 |
| Aug 23, 2023 | Jonathan C. Javitt Director, Officer (Chief Scientist), 10% owner | Open-market purchase | +100,000 | $0.33 | $33,000 |
| Aug 22, 2023 | Jonathan C. Javitt Director, Officer (Chief Scientist), 10% owner | Open-market purchase | +200,000 | $0.32 | $64,000 |
| Dec 14, 2022 | Jonathan C. Javitt Director, 10% owner | Gift | −300,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.